ストックスクリーナーアプリを入手
75.19
6.77%
-5.46
アフターアワーズ：
74.70
-0.49
-0.65%
10 X Genomics Inc (TXG) 最新ニュース
10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research - Zacks Investment Research
ARK and Catherine D. Wood report ownership above 5% in 10x Genomics (TXG). - Stock Titan
Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.
10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises - Zacks Investment Research
10x genomics director Shehnaaz Suliman sells $464,667 in stock - Investing.com
Form 4 10X Genomics Inc For: 24 September By Investing.com - Investing.com India
10x genomics director Shehnaaz Suliman sells $464,667 in stock By Investing.com - Investing.com Canada
Form 4 10X Genomics Inc For: 24 September By Investing.com - Investing.com UK
Under a trading plan, a 10x Genomics (TXG) director sells 5,723 shares in five transactions. - Stock Titan
At $77.75 to $82.53 a share, 10x Genomics (TXG) CEO made five sales under a trading plan. - Stock Titan
5,723 10x Genomics (NASDAQ: TXG) shares set for Rule 144 sale - Stock Titan
Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancer - BioSpectrum Asia
Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know - Yahoo Finance
10x Genomics (TXG) CFO Adam Taich Sells 46,388 Shares - GuruFocus
10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com Nigeria
10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com
10x Genomics Inc (TXG) Shares Surge 3.3% -- What GF Score of 56 Tells Investors - GuruFocus
10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com
10x Genomics (TXG) CFO sells shares under preset trading plan - Stock Titan
Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancer - BioSpectrum Asia
Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancer - BioSpectrum Asia
10x Genomics CFO Adam Taich sells USD 2.99 million in common shares - Bitget
10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com UK
10x Genomics Insider Sold Shares Worth $2,995,470, According to a Recent SEC Filing - Yahoo Finance
10x Genomics to Use Lunit’s AI-Powered Pathology Platform for Oncology Biomarker Discovery - GenomeWeb
AI will pair tissue scans with molecular maps in cancer studies - Stock Titan
10x genomics director Stuelpnagel sells $1.2 million in shares By Investing.com - Investing.com Australia
10x Genomics (NASDAQ: TXG) executive plans multimillion-dollar stock sale - Stock Titan
10x Genomics Insider John R. Stuelpnagel Sells 20,000 Shares Between $60.66 and $62.61 on September 3, 2026 (NASDAQ: TXG) - kalkinemedia.com
10x Genomics stock hits 52-week high at 66.95 USD By Investing.com - Investing.com South Africa
10x Genomics Insider Sold Shares Worth $1,235,072, According to a Recent SEC Filing - Yahoo Finance
Macrogen to offer 10x Genomics spatial biology platform in Asia first - Korea Biomedical Review
10x genomics director Stuelpnagel sells $1.2 million in shares - Investing.com
10x Genomics Inc (TXG) Stock Up 4.7% but GF Value Says Overvalued -- GF Score: 56/100 - GuruFocus
10x Genomics (TXG) director offloads 20,000 shares in open-market trades - Stock Titan
T. Rowe Price reports 10%+ holding in 10x Genomics (TXG) - Stock Titan
Stifel reiterates Buy rating on 10X Genomics stock - investing.com
10X Genomics Inc (TXG) Key Financial Ratios – Valuation, Profitability & More - Value Research
10x Genomics (TXG) CEO holds 1,075,249 shares after 100-share gift - Stock Titan
Founder trust at 10x Genomics (NASDAQ: TXG) moves to sell 20,000 shares - Stock Titan
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead? - finance.yahoo.com
TXG Stock Price and Chart — NASDAQ:TXG - TradingView
A Look at 10x Genomics Inc (TXG) After 4.0% Decline -- GF Value $18.36 vs Price $60.00 - GuruFocus
RBC Capital initiates 10X Genomics stock with Sector Perform rating - investing.com
10X GENOMICS, INC. : RBC INITIATES COVERAGE WITH SECTOR PERFORM RATING; TARGET PRICE $70 - Bitget
10X GENOMICS, INC. : RBC INITIATES COVERAGE WITH SECTOR PERFORM RATING; TARGET PRICE $70 - Bitget
Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit - Benzinga
TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences - TradingView
10X Genomics Inc (TXG) Peer Comparison – Compare with Others - Value Research
10x Genomics Wins Patent Infringement Verdict against Parse Biosciences - marketscreener.com
8.33%
0.48%
大文字化:
|
ボリューム (24 時間):